Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: A well tolerated adjuvant regimen

Cancer

Volumn 95, Issue 4, 2002, Pages 696-703

  Isaac, Neil ^a   Panzarella, Tony ^b   Lau, Anthea ^b   Mayers, Catherine ^b   Kirkbride, Peter ^a,c   Tannock, Ian F ^b   Vallis, Katherine A ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c WESTON PARK HOSPITAL   (United Kingdom)

Author keywords

Adjuvant radiotherapy (RT); Breast carcinoma; Concurrent chemoradiotherapy; Cyclophosphamide, methotrexate, and 5 fluorouracil (CMF); Toxicity

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL KILLING; DRUG EFFECT; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; METHOTREXATE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE;

EID: 0037102966     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10744     Document Type: Article

References (35)

1. Consensus statement on postmastectomy radiation therapy
2. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer
3. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy
4. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer
5. Effect of delay in radiation in the combined modality treatment of breast cancer
6. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer
7. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
8. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy
9. Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma: Side effects, quality of life, and daily organization
10. Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer
11. Analysis of the prognostic effects of inclusion in a clinical trial and of myelosupression on survival after adjuvant chemotherapy for breast carcinoma
12. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
13. "Classical" CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer. An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)
14. Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control?
15. Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer
16. Analysis of local regional relapses in patients with early breast cancers treated by excision and radiotherapy: Experience of the Institut Gustave-Roussy
17. Importance of timing of radiotherapy in breast conserving treatment for early stage breast cancer
18. Duration and reintroduction of adjuvant chemotherapy for node positive premenopausal breast cancer patients
19. Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients
20. Simultaneous adjuvant radiation therapy and chemotherapy in high-risk breast cancer-toxicity and dose modification: A Trans-Tasman Radiation Oncology Group multi-institution study
21. Simultaneous adjuvant radiotherapy and chemotherapy for Stage I and II breast cancer
22. Polychemotherapy for early breast cancer: An overview of the randomised trials
23. Patient participation in medical decision-making: A French study in adjuvant radiochemotherapy for early breast cancer
24. Treatment of cancer with radiation and drugs
25. Chemoradiation for malignant epithelial tumors
26. Sequencing of chemotherapy and radiation in lymph node-negative breast cancer
27. An acute toxicity study on the effects of synchronous chemotherapy and radiotherapy in early stage breast cancer after conservative surgery
28. Early and late normal-tissue injury after postmastectomy radiotherapy alone or combined with chemotherapy
29. Traitement adjuvant des cancers du sein par radiochimiothérapie concomitante: Étude de faisabilité d'une nouvelle alternative stratégique dans les stades I et II
30. Concurrent CMF and radiation therapy for early stage breast cancer: Results of a pilot study
31. The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy
32. Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results